Brief: TherapeuticsMD Announces First Quarter 2026 Financial Results
May 12 (Reuters) - TherapeuticsMD Inc TXMD.O: THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS Source text: ID:nBw80SKNna Further company coverage: TXMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract